Production process for cell-based coffee published
Scientists led by Heiko Rischer from the Finnish research centre VTT have published the proof of concept for cell-based coffee production.
Germany blocking deregulation of NGT breeds
At the EU Council (10-11 December), agriculture ministers did not reach the qualified majority required to adopt the <link https://data.consilium.europa.eu/doc/document/ST-16443-2023-INIT/en/pdf>adapted version of the EU Commission’s draft regulation</link> on new genomic […]
Germany blocks deregulation of NGT breeds
At the EU Council (10-11 December), agriculture ministers did not reach the qualified majority required to adopt the <link https://data.consilium.europa.eu/doc/document/ST-16443-2023-INIT/en/pdf>adapted version of the EU Commission’s draft regulation</link> on new genomic […]
Cathera SA closes Series B round at €42m
Sorbonne University spin-out Carthera SA has closed its Series B financing round with an additional investment of €4.5m at €42m to launch clinical trials.<br /> <br />
UK publishes £2bn vision for engineering biology
On the occasion of SynbiTECH in London, British Science, Research and Innovation Minister, Andrew Griffith, unveiled a £2bn strategic 10-year plan to foster engineering biology.
Valnevas Lyme vaccine trial complets recruitment
Pfizer and Valneva announced the completion of enrolment in Phase 3 VALOR trial for Lyme borreliosis vaccine candidate VLA15. More then 9,000 participants were enrolled.
Unveiling prostate cancer's Achilles' heel
Researchers uncover a potential strategy to target and inhibit the androgen receptor in aggressive prostate cancer by exploiting protein droplets.
$30m for genetic medicine advancements
Eligo Bioscience secures $30m in series B funding, advancing its innovative gene-editing solutions targeting diseases linked to bacterial genes within the human microbiome.
Takeover in ADC space: Abbvie snags ImmunoGen
AbbVie buys ImmunoGen in US$10 billion deal, gains access to ADC for ovarian cancer. The ADC space gets hotter and hotter.
AI protein specialist Cradle raises US$24m in Series A financing
Generative AI protein engineering specialist Cradle NV, has raised US$24m in a Series A financing round led by Index Ventures w